Hunting Hill Global Capital’s Surmodics SRDX Stock Holding History

Hunting Hill Global Capital’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9,003	Closed	-$269K	–	147
2025 Q3	$269K	Sell	9,003 -3,229	-26%	-$108K	0.07%	87
2025 Q2	$363K	Sell	12,232 -1,311	-10%	-$37.8K	0.1%	88
2025 Q1	$413K	Buy	13,543 +1,723	+15%	+$58K	0.25%	66
2024 Q4	$468K	Sell	11,820 -3,471	-23%	-$135K	0.17%	54
2024 Q3	$593K	Buy	+15,291	New	+$619K	0.56%	39

Other funds holding SRDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Hunting Hill Global Capital's SRDX Position: Q4 2025 in Review

Hunting Hill Global Capital sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 9,003 shares — an estimated $269K sold.

Hunting Hill Global Capital first reported a position in SRDX in Q3 2024 and held it in 5 quarters. The position peaked at $593K in Q3 2024. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

Hunting Hill Global Capital reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
Hunting Hill Global Capital sold 9,003 Surmodics shares in Q4 2025, an estimated $269K.
Hunting Hill Global Capital first reported a position in Surmodics in Q3 2024 and held it in 5 quarters.
Hunting Hill Global Capital's Surmodics position peaked at $593K in Q3 2024.
1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Hunting Hill Global Capital's 13F filing for Q4 2025, filed 17 Feb 2026.